MSH|^~\&|LAB|SMH|||201910251435||ORU^R01|4090590|D|2.3|||AL|NE
PID|1||LabOruBccdc|LabOruBccdc|LABTESTPOODLE^LUMED^^^^||19501206|M|||123 MAIN ST^^SURREY^BC^V2V 2J5||(555)555-5555|||||LabOruBccdc/19|LabOruBccdc
PV1|1|O|SM.FVCC^^||||LABTESTG1^Labtest^Generic^Doc1^^^^99009^DOC^V2V 2J5|||||||||||RCR||CL|||||||||||||||||||SMH||REG|||201910251407||||||
OBR|1|LabOruBccdc^LAB|00026552^2510:CS00001R^LAB^251019:CS1^LabOruBccdc|523.0890^HEPBSAG^Hep B Surface Antigen -Active^^^XBC411-0||201910251412|201910251409|||||||201910251409||LABTESTG1^Labtest^Generic^Doc1^^^^99009^DOC^V2V 2J5||||||||LAB|F||^^^^^R|LABTESTG2^Labtest^Generic^Doc2^^^^^DOC^V2H 3H5~LABTESTG1^Labtest^Generic^Doc1^^^^99009^DOC^V2V 2J5|
OBX|1|ST|523.0815^HEPBSAB BMARKER^Hepatitis B Markers^HBSAG^5193-8^5193-8|1|NON REACTIVE^^N|mIU/mL||N||A^S|F|||201910251435|BCCDCI^*BC Centre for Disease Control^1-877-747-2522^L

MSH|^~\&|LAB|ARH|||201912271140||ORU^R01|4133788|D|2.3|||AL|NE
PID|1||BccdciOrderAndResult|BccdciOrderAndResult|LABTESTMALTESE^LUMED^||19901001|F||||||||||BccdciOrderAndResult/19|BccdciOrderAndResult
OBR|1|BccdciOrderAndResult^LAB|00028039^2312:CS00002R^LAB^BccdciOrderAndResult:CS2^BccdciOrderAndResult|523.0690^HEPATOT^Hep A Total Antibody -Immunity^^^51913-2||201912231025|201912231014|||||||201912231014||||||||||LAB|F||||
OBX|1|ST|523.0710^HEPATOT R^Hepatitis A Total Antibody^HAAT^51913-2^51913-2|1|NON REACTIVE^^N|||N||A^S|F|||201912271140
OBR|2|BccdciOrderAndResult^LAB|00028039^2312:CS00002R^LAB^BccdciOrderAndResult:CS2^BccdciOrderAndResult|523.0790^HEPBSAB^Hep B Surface Antibody-Imunity^^^5193-8||201912231025|201912231014|||||||201912231014||||||||||LAB|F||||
OBX|1|ST|523.0810^HEPBSAB R^Hepatitis B Surface Antibody^HBSAB^5193-8^5193-8|1|NON REACTIVE^^N|mIU/mL||N||A^S|F|||201912271140
OBX|2|ST|523.1320^HEPB RPT^Hepatitis B Interpretation^XXX^XXX-0587^XXX-0587|1|^^N|||N||A^S|F|||201912271140
NTE|1||This is hte interpretation for the Hepatitis B test.
OBR|3|BccdciOrderAndResult^LAB|00028039^2312:CS00002R^LAB^BccdciOrderAndResult:CS2^BccdciOrderAndResult|523.1390^HEPC^Hep C Antibody^^^13955-0||201912231025|201912231014|||||||201912231014||||||||||LAB|F||||
OBX|1|ST|523.0907^HEPBSAG R^Hepatitis B Surface Antigen^XXX^5196-1^5196-1|1|NON REACTIVE^^N|||N||A^S|F|||201912271140
OBX|2|ST|523.0909^HEPBSAG NEUT^HepB Surface Ag Neutralization^XXX^7905-3^7905-3|1|NON REACTIVE^^N|||N||A^S|F|||201912271140
OBX|3|ST|523.0911^HEPBSAG SUPP^HepB Surface Ag Supplemental^XXX^XXX-2440^XXX-2440|1|NON REACTIVE^^N|||N||A^S|F|||201912271140
OBX|4|ST|523.1120^HEPBCORTOT NP^Hepatitis B Core Total Ab^XXX^51914-0^51914-0|1|NON REACTIVE^^N|||N||A^S|F|||201912271140
OBX|5|ST|523.1410^HEPC R^Hepatitis C Antibody^HEPCB^13955-0^13955-0|1|NON REACTIVE^^N|||N||A^S|F|||201912271140
OBX|6|ST|523.1420^HEPC RPT^Hepatitis C Antibody Interp^XXX^XXX-0980^XXX-0980|1|^^N|||N||A^S|F|||201912271140
NTE|1||This is the interpretive comment for the Hepatitis C test.

MSH|^~\&|LAB|RCH|||201912301150||ORU^R01|4137053|D|2.3|||AL|NE
PID|1||TuberculosisWithAbnormal|TuberculosisWithAbnormal|LABTEST^JINGLE^||19880615|F||||||||||RCTuberculosisWithAbnormal/19|TuberculosisWithAbnormal
OBR|1|TuberculosisWithAbnormal^LAB|00028066^3012:CS00003R^LAB^TuberculosisWithAbnormal:CS3^TuberculosisWithAbnormal|523.4906^TBIGS^TB Quantiferon Gold Serology^^^71775-1||201912301041|201912301041|||||||201912301041||||||||||LAB|F||||
OBX|1|ST|523.4910^TBQB^TB Spec Desc^ZQFBDS^XXX-0002^XXX-0002|1|Quantiferon Blood^^N|||N||A^S|F|||201912301043
NTE|1||Pre-analytical processing of this sample was performed by
NTE|2||the submitting site.
NTE|3||Analytical testing was performed by the Zoonotic Diseases
NTE|4||and Emerging Pathogens Program, BC Public Health
NTE|5||Microbiology and Reference laboratory.
OBX|2|ST|523.4922^TBQR1^Quantiferon Plus TB Assay^TBQS^XBC2545-8^XBC2545-8|1|Reactive.^^N|||H||A^S|F|||201912301150
NTE|1||(Enzyme Immunoassay)
NTE|2||M. tuberculosis infection likely when either TB antigen is >= 0.35 IU/mL.
NTE|3||Interpretation of IGRA results should include assessment of TB risk factors and
NTE|4||may include diagnostic imaging. For further consultation please contact
NTE|5||Provincial TB services at 604 707 5678 or fax
NTE|6||referral to 604 707 2690.
OBX|3|ST|523.4932^TBQIU2^Quantiferon PLUS TB1 IU/mL^TBIGS^46217-6^46217-6|1|0.45^^N|IU/mL||N||A^S|F|||201912301150
OBX|4|ST|523.4933^TBQIU3^Quantiferon PLUS TB2 IU/mL^TBIGS^88518-6^88518-6|1|0.54^^N|IU/mL||N||A^S|F|||201912301150

MSH|^~\&|LAB|LMH|||202002141351||ORU^R01|4169093|D|2.3|||AL|NE
PID|1||LM00005528TORONTO|LM5330TORONTO|LUMEDTEST^TORONTO^||19880908|F||||||||||LM000762TORONTO/19|9874745485TORONTO
OBR|1|39428^LAB|00029746^1402:CS00003R^LAB^140220:CS3^39428|523.0790^HEPBSAB^Hep B Surface Antibody-Imunity^^^5193-8||202002141338|202002141337|||||||202002141338||||||||||LAB|F||||
OBX|1|ST|523.0810^HEPBSAB R^Hepatitis B Surface Antibody^HBSAB^5193-8^5193-8|1|20^^N|mIU/mL||N||A^S|F|||202002141351
NTE|1||Interpret comments are here.  TEST TEST TEST
NTE|2||More comments are here this is a runon sentence to run onto
NTE|3||the next line test test test more testing for Lumed test
NTE|4||test this is a test words words and more words blah blah
NTE|5||blah.
NTE|6||
NTE|7||This is a new paragraph.
OBX|2|ST|523.4932^TBQIU2^Quantiferon PLUS TB1 IU/mL^TBIGS^46217-6^46217-6|1|0.45^^N|IU/mL||H||A^S|F|||201912301150
NTE|1||This is a test for numeric result with unit and abnormal value

MSH|^~\&|LAB|PAH|||202003171419||ORU^R01|4186994|D|2.3|||AL|NE
PID|1||SU-ORM-ORU|SU-ORM-ORU|MICTEST^TRAPEZOID||19870630|M||||||||||SU-ORM-ORU/17|
OBR|1|40580^LAB|00030585^1703:ML00004R^LAB^170320:ML4^40580|525.0000^COVID19^COVID-19 Virus NAT^^^94309-2||202003171420|202003171419|||||||202003171419||||||||||LAB|F||||
OBX|1|ST|525.0010^COVID19SPEC^COVID-19 Virus Specimen Type^COVD19^XXX-0002^XXX-0002|1|Nasopharyngeal Swab^^N|||N||A^S|F|||202003171419
OBX|2|ST|525.0020^COVID19 R^COVID-19 Virus NAT^COVD19^94309-2^94309-2|1|Negative.^^N|||N||A^S|F|||202003171419

MSH|^~\&|LAB|SMH|||202003181700||ORU^R01|4187841|D|2.3|||AL|NE
PID|1||SM00042062|SM41988|MICTEST^EXHAUSTED^||19700202|M||||||||||SM001890/18|9875972644
OBR|1|40681^LAB|00030669^1803:ML00017R^LAB^180320:ML17^40681|525.0000^COVID19^COVID-19 Virus NAT^^^94309-2||202003181553|202003181553|||||||202003181553||||||||||LAB|F||||
OBX|1|ST|525.0010^COVID19SPEC^COVID-19 Virus Specimen Type^COVD19^XXX-0002^XXX-0002|1|Sputum^^N|||N||A^S|F|||202003181700
OBX|2|ST|525.0020^COVID19 R^COVID-19 Virus NAT^COVD19^94309-2^94309-2|1|Negative.^^N|||N||A^S|F|||202003181700
NTE|1||No COVID-19 virus (2019-nCoV) detected by NAT.
OBX|3|ST|525.0030^COVID19COM^COVID-19 Virus NAT Comment^COVID19^XXX-0024^XXX-0024|1|See Comment^^N|||N||A^S|F|||202003181700
NTE|1||This test targets the RdRP and E gene regions of COVID-19 virus (2019-nCoV).
NTE|2||This is a validated laboratory developed test. Performance characteristics are
NTE|3||available at www.elabhandbook.info/phsa/

MSH|^~\&|LAB|SMH|||202003170823||ORU^R01|4186608|D|2.3|||AL|NE
PID|1||SM00047089|SM46869|MICTEST^HOPEFUL^||20191201|F||||||||||SM004177/19|9874801766
OBR|1|40513^LAB|00030543^1703:ML00003R^LAB^170320:ML3^40513|525.0000^COVID19^COVID-19 Virus NAT^^^94309-2||202003170710|202003170710|||||||202003170710||||||||||LAB|I||||
OBX|1|ST|525.0020^COVID19 R^COVID-19 Virus NAT^COVD19^94309-2^94309-2|1|Positive^^N|||H||A^S|F|||202003170823

MSH|^~\&|LAB|ERH|||202003171419||ORU^R01|4186995|D|2.3|||AL|NE
PID|1||ER00001503|ER1503|LABTEST^BEAGLE^||19520202|F||||||||||ER000004/17|
OBR|1|40582^LAB|00030587^1703:ML00015R^LAB^170320:ML15^40582|525.0000^COVID19^COVID-19 Virus NAT^^^94309-2||202003171121|202003171121|||||||202003171121||||||||||LAB|F||||
OBX|1|ST|525.0010^COVID19SPEC^COVID-19 Virus Specimen Type^COVD19^XXX-0002^XXX-0002|1|See Comment^^N|||N||A^S|F|||202003171419
NTE|1||Nasopharyngeal washings
OBX|2|ST|525.0020^COVID19 R^COVID-19 Virus NAT^COVD19^94309-2^94309-2|1|Positive.^^N|||H||A^S|F|||202003171419
NTE|1||COVID-19 virus (2019-nCoV) DETECTED by NAT.
OBX|3|ST|525.0030^COVID19COM^COVID-19 Virus NAT Comment^COVID19^XXX-0024^XXX-0024|1|See Comment^^N|||N||A^S|F|||202003171419
NTE|1||This test targets the RdRP and E gene regions of COVID-19 virus (2019-nCoV).
NTE|2||This is a validated laboratory developed test. Performance characteristics are
NTE|3||available at www.elabhandbook.info/phsa/

MSH|^~\&|LAB|RCH|||202003171422||ORU^R01|4186996|D|2.3|||AL|NE
PID|1||RC00006059|RC6052|LABTEST^ALASKA^ROLL||19900918|F||||||||||RC000620/19|9876521172
OBR|1|40579^LAB|00030584^1703:ML00013R^LAB^170320:ML13^40579|525.0000^COVID19^COVID-19 Virus NAT^^^94309-2||202003171118|202003171117|||||||202003171117||||||||||LAB|F||||
OBX|1|ST|525.0010^COVID19SPEC^COVID-19 Virus Specimen Type^COVD19^XXX-0002^XXX-0002|1|Nasopharyngeal Swab^^N|||N||A^S|F|||202003171422
NTE|1||HCW1
OBX|2|ST|525.0020^COVID19 R^COVID-19 Virus NAT^COVD19^94309-2^94309-2|1|Indeterminate^^N|||N||A^S|F|||202003171422

MSH|^~\&|LAB|RCH|||202003181700||ORU^R01|4187840|D|2.3|||AL|NE
PID|1||RC00006059|RC6052|LABTEST^ALASKA^ROLL||19900918|F||||||||||RC000620/19|9876521172
OBR|1|40679^LAB|00030667^1803:ML00016R^LAB^180320:ML16^40679|525.0000^COVID19^COVID-19 Virus NAT^^^94309-2||202003181551|202003181550|||||||202003181550||||||||||LAB|F||||
OBX|1|ST|525.0010^COVID19SPEC^COVID-19 Virus Specimen Type^COVD19^XXX-0002^XXX-0002|1|Nasopharyngeal Swab^^N|||N||A^S|F|||202003181700
OBX|2|ST|525.0020^COVID19 R^COVID-19 Virus NAT^COVD19^94309-2^94309-2|1|Indeterminate^^N|||N||A^S|F|||202003181700
NTE|1||Unable to determine if test result is positive or negative.
NTE|2||Poor quality sample.
NTE|3||Please submit new sample if clinically indicated.
OBX|3|ST|525.0030^COVID19COM^COVID-19 Virus NAT Comment^COVID19^XXX-0024^XXX-0024|1|See Comment^^N|||N||A^S|F|||202003181700
NTE|1||This test targets the RdRP and E gene regions of COVID-19 virus (2019-nCoV).
NTE|2||This is a validated laboratory developed test. Performance characteristics are
NTE|3||available at www.elabhandbook.info/phsa/

MSH|^~\&|LAB|ARH|||202004231038||ORU^R01|4207899|D|2.3|||AL|NE
PID|1||AB00007476|AB7515|LABTEST^BUNNY^||20080506|F||||||||||AB000384/18|9875953454
OBR|1|42934^LAB|00032384^2304:ML00021U^LAB^230420:ML21^42934|525.0200^COVID19FH^COVID-19 Virus PCR (FH)^^^||202004230944|202004230948|||||||202004230948||||||||||LAB|F||||
OBX|1|ST|525.0205^COVID19FHSPEC^COVID-19 Virus Specimen Type^^XXX-0002^|1|Bron Alveolar Lavage^^N|||N||A^S|F|||202004231038
OBX|2|ST|525.0210^COVID19FH R^COVID-19 Virus PCR^^94309-2^94309-2|1|POSITIVE^^N|||||A^S|F|||202004231038
NTE|1||Positive for COVID-19 (SARS-CoV-2) RNA by molecular assay
NTE|2||method.
NTE|3||
NTE|4||A copy of the result has been sent to Infection Prevention
NTE|5||and Control.
NTE|6||
NTE|7||Report broadcast to:nurse on ward covid
NTE|8||Date:23/04/20    Time:1037
NTE|9||
NTE|10||As required by the regulation for the control of
NTE|11||communicable disease, this case will be reported to the
NTE|12||Medical Health Officer.